Protective Effects of Antioxidants in Huntington’s Disease: an Extensive Review

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Neurotoxicity research

• Publication date

  2019-01-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12640-018-9989-9PMID 30632085
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mitochondrial Dysfunction in Huntington's Disease.

  2018cited by this paper
• Basal Ganglia Neuromodulation Over Multiple Temporal and Structural Scales—Simulations of Direct Pathway MSNs Investigate the Fast Onset of Dopaminergic Effects and Predict the Role of Kv4.2

  2018cited by this paper
• Does Vitamin C Influence Neurodegenerative Diseases and Psychiatric Disorders?

  2017cited by this paper
• Essential fatty acid-rich diets protect against striatal oxidative damage induced by quinolinic acid in rats

  2017cited by this paper
• Developmental alterations in Huntington's disease neural cells and pharmacological rescue in cells and mice

  2017cited by this paper
• DNA damage related crosstalk between the nucleus and mitochondria.

  2017cited by this paper
• The CREST-E study of creatine for Huntington disease

  2017cited by this paper
• Huntington’s Disease and Mitochondria

  2017cited by this paper
• Taking out the garbage: cathepsin D and calcineurin in neurodegeneration

  2017cited by this paper
• The global prevalence of Huntington's disease: a systematic review and discussion.

  2016cited by this paper
• Time-Course Analysis of Protein and Lipid Oxidation in the Brains of Yac128 Huntington's Disease Transgenic Mice

  2016cited by this paper
• Mitochondrial targeting of XJB-5-131 attenuates or improves pathophysiology in HdhQ150 animals with well-developed disease phenotypes.

  2016cited by this paper
• The Prevalence of Huntington's Disease

  2016cited by this paper
• Neuroprotective Activity of Curcumin in Combination with Piperine against Quinolinic Acid Induced Neurodegeneration in Rats

  2016cited by this paper
• Oxidative Stress and Huntington’s Disease: The Good, The Bad, and The Ugly

  2016cited by this paper
• SIRT2- and NRF2-Targeting Thiazole-Containing Compound with Therapeutic Activity in Huntington's Disease Models.

  2016cited by this paper
• Lycopene and Its Antioxidant Role in the Prevention of Cardiovascular Diseases—A Critical Review

  2016cited by this paper
• N-acetylcysteine modulates glutamatergic dysfunction and depressive behavior in Huntington's disease.

  2016cited by this paper
• Effect of rutin against a mitochondrial toxin, 3-nitropropionicacid induced biochemical, behavioral and histological alterations-a pilot study on Huntington’s disease model in rats

  2016cited by this paper
• ARL3 regulates trafficking of prenylated phototransduction proteins to the rod outer segment.

  2015cited by this paper
• Neuronal identity genes regulated by super-enhancers are preferentially down-regulated in the striatum of Huntington's disease mice.

  2015cited by this paper
• Huntington disease

  2015cited by this paper
• Beyond the redox imbalance: Oxidative stress contributes to an impaired GLUT3 modulation in Huntington's disease.

  2015cited by this paper
• Dopamine and Huntington’s disease

  2015cited by this paper
• RUTIN ATTENUATES 3-NITROPROPIONIC ACID INDUCED BEHAVIOURAL ALTERATIONS AND MITOCHONDRIAL DYSFUNCTION IN THE STRIATUM OF RAT BRAIN

  2015cited by this paper
• PINK1- and PARK2-mediated local mitophagy in distal neuronal axons

  2015cited by this paper
• Importance of selenium and selenoprotein for brain function: From antioxidant protection to neuronal signalling.

  2015cited by this paper
• The Corticospinal Tract in Huntington's Disease.

  2015cited by this paper
• The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease.

  2015cited by this paper
• Combination of lycopene, quercetin and poloxamer 188 alleviates anxiety and depression in 3-nitropropionic acid-induced Huntington’s disease in rats

  2014cited by this paper
• The role of dopamine in Huntington's disease.

  2014cited by this paper
• The role of oxidative stress in Huntington's disease: are antioxidants good therapeutic candidates?

  2014cited by this paper
• Transcriptional dysregulation in Huntington's disease: a failure of adaptive transcriptional homeostasis.

  2014cited by this paper
• Curcumin's Neuroprotective Efficacy in Drosophila Model of Idiopathic Parkinson's Disease Is Phase Specific: Implication of its Therapeutic Effectiveness

  2014cited by this paper
• Effects of creatine supplementation associated with resistance training on oxidative stress in different tissues of rats

  2014cited by this paper
• Curcumin: a new paradigm and therapeutic opportunity for the treatment of osteoarthritis: curcumin for osteoarthritis management

  2013cited by this paper
• The chemistry and biological activities of N-acetylcysteine.

  2013cited by this paper
• Oxidative stress, mitochondrial damage and neurodegenerative diseases

  2013cited by this paper
• The promise of N-acetylcysteine in neuropsychiatry.

  2013cited by this paper
• Striatal parvalbuminergic neurons are lost in Huntington's disease: implications for dystonia

  2013cited by this paper
• Emerging roles of Nrf2 and phase II antioxidant enzymes in neuroprotection.

  2013cited by this paper
• A failure in energy metabolism and antioxidant uptake precede symptoms of Huntington’s disease in mice

  2013cited by this paper
• Correlations between behavioural and oxidative parameters in a rat quinolinic acid model of Huntington's disease: protective effect of melatonin.

  2013cited by this paper
• Large Genetic Animal Models of Huntington's Disease

  2013cited by this paper
• Probucol Increases Striatal Glutathione Peroxidase Activity and Protects against 3-Nitropropionic Acid-Induced Pro-Oxidative Damage in Rats

  2013cited by this paper
• Circadian and sleep disorder in Huntington's disease.

  2013cited by this paper
• Curcumin Induces Nrf2 Nuclear Translocation and Prevents Glomerular Hypertension, Hyperfiltration, Oxidant Stress, and the Decrease in Antioxidant Enzymes in 5/6 Nephrectomized Rats

  2012cited by this paper
• Hippocampal Neurogenesis, Cognitive Deficits and Affective Disorder in Huntington's Disease

  2012cited by this paper
• Effects of Panax ginseng in Neurodegenerative Diseases

  2012cited by this paper
• Targeting of XJB-5-131 to mitochondria suppresses oxidative DNA damage and motor decline in a mouse model of Huntington's disease.

  2012cited by this paper
• Therapeutic Strategies for Huntingtons Disease: From the Bench to the Clinic

  2012cited by this paper
• The incidence and prevalence of Huntington's disease: A systematic review and meta‐analysis

  2012cited by this paper
• Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice.

  2012cited by this paper
• Cognitive Dysfunction in Huntington's Disease: Humans, Mouse Models and Molecular Mechanisms

  2012cited by this paper
• Huntingtin protein interactions altered by polyglutamine expansion as determined by quantitative proteomic analysis

  2012cited by this paper
• N-Acetylcysteine Reverses Mitochondrial Dysfunctions and Behavioral Abnormalities in 3-Nitropropionic Acid-Induced Huntington’s Disease

  2012cited by this paper
• Organoselenium Bis Selenide Attenuates 3-Nitropropionic Acid-Induced Neurotoxicity in Rats

  2012cited by this paper
• Gene expression and behaviour in mouse models of HD.

  2012cited by this paper
• Mitochondrial Dysfunction in Neurodegenerative Diseases

  2012cited by this paper
• N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action.

  2011cited by this paper
• Hugging tight in Huntington's

  2011cited by this paper
• Important role of oxidative stress biomarkers in Huntington's disease.

  2011cited by this paper
• Neuroprotective effects of creatine

  2011cited by this paper
• Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage.

  2011cited by this paper
• Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function.

  2011cited by this paper
• FK506 ameliorates cell death features in Huntington's disease striatal cell models.

  2011cited by this paper
• PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility.

  2011cited by this paper
• MUTANT HUNTINGTIN BINDS THE MITOCHONDRIAL FISSION GTPASE DRP1 AND INCREASES ITS ENZYMATIC ACTIVTY

  2011cited by this paper
• Molecular mechanisms and potential therapeutical targets in Huntington's disease.

  2010cited by this paper
• Metabotropic Glutamate Receptor-Mediated Cell Signaling Pathways Are Altered in a Mouse Model of Huntington's Disease

  2010cited by this paper
• Safety and tolerability of high‐dosage coenzyme Q10 in Huntington's disease and healthy subjects

  2010cited by this paper
• Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease.

  2010cited by this paper
• Lipid Oxidation and Peroxidation in CNS Health and Disease: From Molecular Mechanisms to Therapeutic Opportunities

  2010cited by this paper
• Mitochondria in Huntington's disease.

  2010cited by this paper
• Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntington's like symptoms in rats: possible role of nitric oxide.

  2010cited by this paper
• Dysregulation of intracellular dopamine stores revealed in the R6/2 mouse striatum

  2010cited by this paper
• Possible role of vitamin E, coenzyme Q10 and rutin in protection against cerebral ischemia/reperfusion injury in irradiated rats

  2010cited by this paper
• Protein oxidation in Huntington disease affects energy production and vitamin B6 metabolism.

  2010cited by this paper
• Mitochondrial fission and cristae disruption increase the response of cell models of Huntington's disease to apoptotic stimuli

  2010cited by this paper
• Possible nitric oxide modulation in protective effect of FK-506 against 3-nitropropionic acid-induced behavioral, oxidative, neurochemical, and mitochondrial alterations in rat brain

  2010cited by this paper
• Dopamine and Glutamate in Huntington's Disease: A Balancing Act

  2010cited by this paper
• Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington's disease.

  2010cited by this paper
• Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington's disease.

  2010cited by this paper
• Dynamic regulation of mitochondrial fission through modification of the dynamin‐related protein Drp1

  2010cited by this paper
• A metabolic switch in brain: glucose and lactate metabolism modulation by ascorbic acid

  2009cited by this paper
• Melatonin pretreatment attenuates 2-bromopropane-induced testicular toxicity in rats.

  2009cited by this paper
• Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease.

  2009cited by this paper
• Combination therapy with Coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson’s and Huntington’s Diseases

  2009cited by this paper
• [The molecular bases of Huntington's disease: the role played by oxidative stress].

  2009cited by this paper
• Protective effect of selaginellin on glutamate-induced cytotoxicity and apoptosis in differentiated PC12 cells

  2009cited by this paper
• Mouse models of Huntington's disease and methodological considerations for therapeutic trials.

  2009cited by this paper
• Bases moleculares de la enfermedad de Huntington: Papel del estrés oxidativo

  2009cited by this paper
• Nerve cell loss in the thalamic centromedian-parafascicular complex in patients with Huntington’s disease

  2009cited by this paper
• Huntington disease (chorea) in the middle East.

  2009cited by this paper
• Age-Dependent Alterations of Corticostriatal Activity in the YAC128 Mouse Model of Huntington Disease

  2009cited by this paper
• Role of mitochondrial dysfunction in the pathogenesis of Huntington's disease.

  2009cited by this paper
• Delayed onset of the diurnal melatonin rise in patients with Huntington’s disease

  2009cited by this paper
• Olive Oil and Cognition: Results from the Three-City Study

  2009cited by this paper
• Idebenone: An emerging therapy for Friedreich ataxia

  2009cited by this paper
• Effect of lycopene and epigallocatechin-3-gallate against 3-nitropropionic acid induced cognitive dysfunction and glutathione depletion in rat: a novel nitric oxide mechanism.

  2009cited by this paper

• Bidirectional Communication Network: Exploring the Gut-Brain Axis as a Target for Ocimum Gratissimum Modulation in Neurodegenerative Disorder

  2025cites this paper
• Sulfated polysaccharides of Caulerpa cupressoides var. flabellata: An investigation into their antioxidant properties and biocompatibility

  2025cites this paper
• Microbiota dysbiosis impact on the immune system dysregulation in Huntington's disease (HD).

  2025cites this paper
• Advanced strategies for enhancing the neuroprotective potential of curcumin: delivery systems and mechanistic insights in neurodegenerative disorders

  2025cites this paper
• Barbigerone attenuates 3-nitropropionic acid-induced Huntington’s disease-like neuropathology in rats via antioxidant, anti-inflammatory, and neuroprotective mechanisms

  2025cites this paper
• Antioxidant Activity of Radix Cyathula officinalis Kuan Polysaccharides and Their Modulatory Effects on the Gut Microbiota of Caenorhabditis elegans

  2025cites this paper
• The interplay of oxidative stress and neurodegeneration: Nanoantioxidants as a novel therapeutic approach

  2025cites this paper
• Neuroprotective Effects of Curcumin in Neurodegenerative Diseases

  2024cites this paper
• Polygonatum Sibiricum Polysaccharides: A Promising Strategy in the Treatment of Neurodegenerative Disease.

  2024cites this paper
• Recent Advances in the Synthesis of Antioxidant Derivatives: Pharmacological Insights for Neurological Disorders.

  2024cites this paper
• Targeted Treatment Strategies for Mitochondria Dysfunction: Correlation with Neurological Disorders.

  2024cites this paper
• New Insights into Oxidative Stress and Inflammatory Response in Neurodegenerative Diseases

  2024cites this paper
• Sesamol: A Phenolic Compound of Health Benefits and Therapeutic Promise in Neurodegenerative Diseases.

  2023cites this paper
• Huntington’s Disease Drug Development: A Phase 3 Pipeline Analysis

  2023cites this paper
• Small Molecule Pytren-4QMn Metal Complex Slows down Huntington’s Disease Progression in Male zQ175 Transgenic Mice

  2023cites this paper
• Nanovesicular-Mediated Intranasal Drug Therapy for Neurodegenerative Disease

  2023cites this paper
• Oxidative stress, the blood–brain barrier and neurodegenerative diseases: The critical beneficial role of dietary antioxidants

  2023cites this paper
• Cell Rearrangement and Oxidant/Antioxidant Imbalance in Huntington’s Disease

  2023cites this paper
• Contribution of neuroinflammation, resolution, and neuroprotection in neuropsychiatric diseases

  2022cites this paper
• Quercetin and its role in reducing the expression of pro-inflammatory cytokines in osteoarthritis.

  2022cites this paper
• Ameliorating potential of curcumin and its analogue in central nervous system disorders and related conditions: A review of molecular pathways

  2022cites this paper
• An Overview of Oxidative Stress, Neuroinflammation, and Neurodegenerative Diseases

  2022cites this paper
• Cross talk mechanism of disturbed sleep patterns in neurological and psychological disorders.

  2022cites this paper
• Siah-1-interacting protein regulates mutated huntingtin protein aggregation in Huntington’s disease models

  2022cites this paper
• Enriched Environment and Exercise Enhance Stem Cell Therapy for Stroke, Parkinson’s Disease, and Huntington’s Disease

  2022cites this paper
• Nutritional interventions for the prevention and treatment of neurological disorders such as anxiety, bipolar disorder, depression, epilepsy, multiple sclerosis, and schizophrenia

  2022cites this paper
• Contribution of neuroinflammation, resolution, and neuroprotection in neurodegenerative diseases

  2022cites this paper
• Synthesis, crystal structure and antioxidant activity of butylphenol Schiff bases: experimental and DFT study

  2021cites this paper
• Redox Imbalance Associates with Clinical Worsening in Spinocerebellar Ataxia Type 2

  2021cites this paper
• A cut above the rest: oxidative stress in chronic wounds and the potential role of polyphenols as therapeutics.

  2021cites this paper
• Rice bran, an off-shoot to newer therapeutics in neurological disorders.

  2021cites this paper
• Disease Modifying Potential of Functional Foods for Neurodegenerative Disorders: Status Update on Regulatory Compliance

  2021cites this paper
• Zebrafish an experimental model of Huntington’s disease: molecular aspects, therapeutic targets and current challenges

  2021cites this paper
• Non-Cell Autonomous and Epigenetic Mechanisms of Huntington’s Disease

  2021cites this paper
• Coenzyme Q10 effects in neurological diseases.

  2021cites this paper
• Association of Oxidative Stress with Neurological Disorders

  2021cites this paper
• Sleep Deprivation and Neurological Disorders

  2020cites this paper
• Pursuing the Elixir of Life: In Vivo Antioxidative Effect of Manganosalen Complexes, a Review

  2020cites this paper
• Recent advances and possibilities for the use of plant phenolic compounds to manage ageing-related diseases

  2020cites this paper
• Isolation and Identification of a Novel Anti-protein Aggregation Activity of Lignin-Carbohydrate Complex From Chionanthus retusus Leaves

  2020cites this paper
• Pursuing the Elixir of Life: In Vivo Antioxidative Effects of Manganosalen Complexes

  2020cites this paper
• Interaction of Oxidative Stress and Misfolded Proteins in the Mechanism of Neurodegeneration

  2020cites this paper
• Therapeutic and Mechanistic Effects of Curcumin in Huntington’s Disease

  2020cites this paper
• Antioxidative Activity of 1,3,5-Triazine Analogues Incorporating Aminobenzene Sulfonamide, Aminoalcohol/Phenol, Piperazine, Chalcone, or Stilbene Motifs

  2020cites this paper
• Harmine Acts as an Indirect Inhibitor of Intracellular Protein Aggregation

  2020cites this paper
• Mitochondria-targeted drug delivery in neurodegenerative diseases

  2020cites this paper
• Integrated adrenal and testicular metabolomics revealed the protective effects of Guilingji on the Kidney-Yang deficiency syndrome rats.

  2020cites this paper
• Inhibition of Mitochondrial ROS by MitoQ Alleviates White Matter Injury and Improves Outcomes after Intracerebral Haemorrhage in Mice

  2020cites this paper
• Biocompatible Inhibitor Based on Chitosan and Amphiphilic Peptide against Mutant Huntingtin Toxicity

  2019cites this paper
• Telomere length analysis on leukocytes derived from patients with Huntington Disease.

  2019cites this paper
• Benefits of curcumin in brain disorders

  2019cites this paper
• Increased plasma melatonin in presymptomatic Huntington disease sheep (Ovis aries): Compensatory neuroprotection in a neurodegenerative disease?

  2019cites this paper
• Protection from the Pathogenesis of Neurodegenerative Disorders, including Alzheimer’s Disease, Amyotrophic Lateral Sclerosis, Huntington’s Disease, and Parkinson’s Diseases, through the Mitigation of Reactive Oxygen Species

  2019influential citation
• Pseudo-Enzymatic Properties of Haptoglobin:Hemoglobin Complexes

  2019cites this paper
• Nutraceuticals and physical activity: their role on oxysterols-mediated neurodegeneration.

  2019cites this paper
• The neuroprotection of liraglutide on diabetic cognitive deficits is associated with improved hippocampal synapses and inhibited neuronal apoptosis.

  2019cites this paper